Merck

(Image: Getty/Golubovy)

Top five stories from September

By Ben Hargreaves

The news most interesting to our readers were those featuring collaborations, whether in the production of an Ebola vaccine, biosimilars entering new markets or creating new manufacturing modalities.

(Image: Getty/Esben_H)

Vaccine investment breathing new life into space?

By Ben Hargreaves

Once a neglected area of pharma research, companies are now investing heavily after several major commercial successes and with promising new avenues of research progressing.